For 20 years, federal health and justice officials have concocted and applied a warped set of legal principles which essentially prohibit medical product makers from sharing truthful information (even peer-reviewed journalarticles) with doctors about off-label uses.
One provision restricts the ability of drug makers to use sales and marketing personnel to distribute peer reviewed reprints of journalarticles that contain off-label information.